Latest Breaking News On - Prnewswire toosonix - Page 1 : comparemela.com

TOOsonix receives MDR CE Mark for its new oncology and dermatology device

TOOsonix receives MDR CE Mark for its new oncology and dermatology device
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire toosonixTomasz zawadaTorsten boveDevice regulationEuropean economicManaging directorCo managing directorNeurofibromatosis typeConsolidated holdings

TOOsonix A/S: TOOsonix receives MDR CE Mark for its new oncology and dermatology device

TOOsonix A/S: TOOsonix receives MDR CE Mark for its new oncology and dermatology device
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesTorsten boveTomasz zawadaPrnewswire toosonixDevice regulationEuropean economicManaging directorCo managing directorNeurofibromatosis typeConsolidated holdingsBasal cellIhr portfolio

TOOsonix receives MDR CE Mark for its new oncology and dermatology device | Taiwan News

TOOsonix receives MDR CE Mark for its new oncology and dermatology device | Taiwan News
taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire toosonixTomasz zawadaTorsten boveDevice regulationEuropean economicManaging directorCo managing directorNeurofibromatosis typeConsolidated holdingsBasal cell

TOOsonix announces granted patents for its non-invasive treatments of dermatological conditions

/PRNewswire/ TOOsonix A/S, a pioneer in high intensity focused ultrasound (HIFU) technology for dermatology, today announced that the United States Patent.

United statesTomasz zawadaPrnewswire toosonixTorsten boveSchoett kunoeeTrademark officeUnited states patentBasal cell carcinomaCutaneous neurofibromaConsolidated holdingsToosonixa s

TOOsonix A/S: TOOsonix announces granted patents for its non-invasive treatments of dermatological conditions

TOOsonix A/S secures intellectual property rights in USA, Europe and China. The patents define methods for non-invasive and real-time image-guided treatment of skin using therapeutic ultrasound. HOERSHOLM

United statesTomasz zawadaKostenloser wertpapierhandelPrnewswire toosonixTorsten boveSchoett kunoeeTrademark officeToosonix technologyUnited states patentBasal cell carcinomaCutaneous neurofibromaConsolidated holdings